Vanderbilt University School of Medicine Basic Sciences: Targeting Immune Suppression to Overcome Melanoma Resistance
February 17, 2026
February 17, 2026
NASHVILLE, Tennessee, Feb. 17 (TNSjou) -- Vanderbilt University School of Medicine Basic Sciences issued the following news:
* * *
Targeting immune suppression to overcome melanoma resistance
For patients with advanced melanoma without BRAF mutation who no longer respond to immune checkpoint inhibitors, treatment options remain frustratingly limited. A new study from Vanderbilt researchers led by Professor Emerita of Pharmacology Ann Richmond outlines a pro . . .
* * *
Targeting immune suppression to overcome melanoma resistance
For patients with advanced melanoma without BRAF mutation who no longer respond to immune checkpoint inhibitors, treatment options remain frustratingly limited. A new study from Vanderbilt researchers led by Professor Emerita of Pharmacology Ann Richmond outlines a pro . . .